Dipeptidyl peptidase 4 (DPP-4) inhibitors
Empagliflozin and Linagliptin
The FDA lists this product in 3 strengths and forms.
Composition
- Active ingredients
- EMPAGLIFLOZIN 25MG; LINAGLIPTIN 5MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- EMPAGLIFLOZIN 25MG; LINAGLIPTIN 5MG · TabletThis page
- EMPAGLIFLOZIN 10MG; LINAGLIPTIN 5MG · TabletANDA212359-001 · Tentative approval
- EMPAGLIFLOZIN 25MG; LINAGLIPTIN 5MG · TabletANDA212359-002 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA212264.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.